In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
In this commentary, Dr Seth Martin explains the updates to the Friedewald estimation that he hopes more labs will adopt to ensure LDL assessments are as accurate as possible.
In this commentary, Dr Sarika Desai from Arizona Heart 360 gives advice about how to start a conversation about lifestyle modification, weight loss, and more with younger patients.
Previous reports have suggested that mean blood pressure (BP) increased during the early years of the COVID-19 pandemic across the United States.1 There have been many hypotheses regarding why–including...
In this article Michael J. Bloch, MD, writes about the potential use of a polypill for cardiovascular disease prevention and discusses how the results of recent research supports the potential use in the...
